Wilson Martin (CIK 1704342) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-21). Recent activity: Sell RCKT (662 shares), Sell RCKT (3,361 shares), Sell RCKT (1,376 shares), Sell RCKT (12,253 shares), Buy RCKT (311,813 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-21 | ROCKET PHARMACEUTICALS, INC. (RCKT) | General Counsel | Sell | 662 | $1,995 |
| 2026-05-14 | ROCKET PHARMACEUTICALS, INC. (RCKT) | General Counsel | Sell | 3,361 | $12,120 |
| 2026-02-20 | ROCKET PHARMACEUTICALS, INC. (RCKT) | General Counsel | Sell | 1,376 | $4,596 |
| 2026-02-18 | ROCKET PHARMACEUTICALS, INC. (RCKT) | General Counsel | Sell | 12,253 | $40,557 |
| 2026-02-13 | ROCKET PHARMACEUTICALS, INC. (RCKT) | General Counsel | Buy | 311,813 | $0 |
| 2025-11-20 | ROCKET PHARMACEUTICALS, INC. (RCKT) | General Counsel | Sell | 1,646 | $4,905 |
| 2025-11-10 | ROCKET PHARMACEUTICALS, INC. (RCKT) | General Counsel | Buy | 100,000 | $0 |
| 2025-09-09 | ROCKET PHARMACEUTICALS, INC. (RCKT) | General Counsel | Buy | 150,000 | $0 |
| 2025-08-20 | ROCKET PHARMACEUTICALS, INC. (RCKT) | General Counsel | Sell | 1,004 | $3,082 |
| 2025-08-20 | ROCKET PHARMACEUTICALS, INC. (RCKT) | General Counsel | Sell | 588 | $1,764 |
| 2025-08-18 | ROCKET PHARMACEUTICALS, INC. (RCKT) | General Counsel | Sell | 12,109 | $36,569 |
| 2025-05-22 | ROCKET PHARMACEUTICALS, INC. (RCKT) | General Counsel | Sell | 587 | $3,786 |
| 2025-05-20 | ROCKET PHARMACEUTICALS, INC. (RCKT) | General Counsel | Sell | 946 | $6,177 |
| 2025-02-25 | ROCKET PHARMACEUTICALS, INC. (RCKT) | General Counsel | Sell | 3,222 | $34,089 |
| 2025-02-13 | ROCKET PHARMACEUTICALS, INC. (RCKT) | General Counsel | Buy | 90,358 | $0 |
Source: SEC Form 4 filings · as of 2026-05-21